Cardinal Health (CAH) to Release Quarterly Earnings on Tuesday

Key Points

• Cardinal Health is set to announce its Q4 2025 quarterly earnings on Tuesday, August 12th, with projected earnings of $2.03 per share and revenue of $60.91 billion.
• Shares traded up to $159.12 with a market cap of $37.98 billion, while the stock has fluctuated between a 12-month low of $96.05 and a high of $168.44.
• Analysts are bullish on Cardinal Health, with several brokerages raising their price targets, and a consensus rating of "Moderate Buy" according to MarketBeat.

Cardinal Health (NYSE:CAH - Get Free Report) will likely be posting its Q4 2025 quarterly earnings results before the market opens on Tuesday, August 12th. Analysts expect Cardinal Health to post earnings of $2.03 per share and revenue of $60.91 billion for the quarter.

Cardinal Health Price Performance

Shares of NYSE:CAH traded up $0.50 during midday trading on Tuesday, hitting $159.12. 300,023 shares of the company's stock were exchanged, compared to its average volume of 2,360,175. Cardinal Health has a 12 month low of $96.05 and a 12 month high of $168.44. The company has a market cap of $37.98 billion, a PE ratio of 24.81, a price-to-earnings-growth ratio of 1.55 and a beta of 0.67. The stock has a 50 day moving average price of $159.86 and a 200-day moving average price of $143.16.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cardinal Health stock. Integrated Wealth Concepts LLC raised its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,363 shares of the company's stock after acquiring an additional 280 shares during the period. Integrated Wealth Concepts LLC's holdings in Cardinal Health were worth $601,000 as of its most recent filing with the Securities & Exchange Commission. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CAH. Morgan Stanley lifted their price target on Cardinal Health from $181.00 to $190.00 and gave the company an "overweight" rating in a report on Wednesday, July 16th. Robert W. Baird increased their target price on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research report on Friday, May 2nd. Wells Fargo & Company raised shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Citigroup reiterated a "neutral" rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Finally, Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average price target of $158.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.